title: Psychotropic medication use during pregnancy: changes to the labeling system and the importance of exposure registries.
abstract: In this issue of JCP, Cohen et al present the methodology of the National Pregnancy Registry for Atypical Antipsychotics (NPRAA). In full disclosure, the investigators are my colleagues, and I have great interest in the topic of pregnancy registries, including this particular registry, as a perinatal psychiatrist and from a scientific perspective. Highlighting the importance of this paper is intuitive because we are at a defining moment in the application of data to inform the care of pregnant women.
authors.affiliation: mfreeman@psychiatrist.com.
authors.forename: Marlene P
authors.initials: MP
authors.lastname: Freeman
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000453:epidemiology*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology*; D011256:Pregnancy Outcome / Q000453:epidemiology*; D012042:Registries / Q000706:statistics & numerical data*
chemical_list: D014150:Antipsychotic Agents